ArticleJPGN reports2026
Transnasal endoscopy for eosinophilic esophagitis surveillance in adolescents with mild autism spectrum disorder: A single-center case series.
Article in JPGN reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Children with autism spectrum disorder (ASD) often experience sensory sensitivities and procedural anxiety, which can complicate sedated esophagogastroduodenoscopy (EGD). Transnasal endoscopy (TNE) is a less invasive, unsedated alternative, but data on its use in this population are limited. We evaluated the safety, tolerability, and clinical utility of sedation-free TNE in adolescents with Level 1 ASD (mild autism) undergoing surveillance for eosinophilic esophagitis (EoE). In this retrospective case series, five adolescents (mean age 13.2 years; 80% male) underwent TNE between April 2024 and April 2025. We assessed procedural success, adverse events, biopsy adequacy, and behavioral strategies. All procedures were completed successfully without sedation or serious adverse events. Child Life Specialists (CLSs) supported 80% of cases, using behavioral aids, such as virtual reality (VR) goggles and desensitization tools. Mean procedure time was 10.75 ± 1.96 min. We concluded that TNE is a safe and feasible alternative to sedated EGD in carefully selected adolescents with mild ASD and warrants further study in larger cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.